Title: Identification of potent Yes1 kinase inhibitors using a library screening approach.
Journal: Bioorganic & medicinal chemistry letters 20130801
Title: A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Journal: The Biochemical journal 20130415
Title: Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.
Journal: Nature biotechnology 20111101
Title: Selective p38alpha inhibitors clinically evaluated for the treatment of chronic inflammatory disorders.
Journal: Journal of medicinal chemistry 20100325
Title: Comparative renal excretion of VX-702, a novel p38 MAPK inhibitor, and methotrexate in the perfused rat kidney model.
Journal: Drug development and industrial pharmacy 20100301
Title: The as-yet unfulfilled promise of p38 MAPK inhibitors.
Journal: Nature reviews. Rheumatology 20090901
Title: Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies.
Journal: Arthritis and rheumatism 20090501
Title: Inhibition of p38: has the fat lady sung?
Journal: Arthritis and rheumatism 20090201
Title: Drug evaluation: VX-702, a MAP kinase inhibitor for rheumatoid arthritis and acute coronary syndrome.
Journal: Current opinion in investigational drugs (London, England : 2000) 20061101
Title: p38 MAP kinase inhibitors: many are made, but few are chosen.
Journal: Current opinion in drug discovery & development 20050701
Title: MAP kinase p38 inhibitors: clinical results and an intimate look at their interactions with p38alpha protein.
Journal: Current medicinal chemistry 20050101
Title: Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation.
Journal: Thrombosis and haemostasis 20041201
